Back to DirectoryParenteral Nutrition
Parenteral Nutrition

Clinimix E 5/10 sulfite free w/ elect in dextrose 10% w/ calcium

Osmolarity: ≈ 1,230 mOsm/LTonicity: HypertonicpH: 5.0 – 6.5 Central Line Required

Clinical Indications

High-protein TPN for hypermetabolic patients (sepsis, major trauma, burns) with moderate caloric requirements. 5% amino acid concentration exceeds standard formulations.

Dosing & Administration Rate

Monitor renal function — high nitrogen load. 1.5–2 g protein/kg/day provided at standard rates.

Warnings & Precautions

High amino acid load — contraindicated in severe renal failure without specialist guidance. Standard TPN monitoring applies.

Contraindications

Known hypersensitivity to amino acids. Severe liver disease or hepatic coma. Severe renal impairment (without dialysis). Abnormalities of amino acid metabolism.

Pharmacology & Safety Profile

Mechanism of Action

Provides a source of biologically utilizable essential and non-essential amino acids for protein synthesis, and dextrose as a source of calories.

Adverse Reactions

Phlebitis, fluid overload, hyperglycemia, hyperosmolar syndrome, electrolyte imbalances, metabolic acidosis, liver enzyme elevations.

Compatibility Notes

Vitamins and trace elements supplemented per protocol.

Electrolyte & Composition Profile

ComponentAmount / Concentration
Amino Acids50 g/L (5%)
Dextrose (Anhydrous)100 mg/mL (10%)
Electrolytes (Na, K, Ca, Mg, Phosphate)Standard Clinimix E panel
Nitrogen Content≈ 7.7 g/L
Caloric Density≈ 740 kcal/L
Nitrogen Content7.7 g N/L

Clinical Parameters

RouteIntravenous (central venous access)
Fluid CategoryParenteral Nutrition
Required MonitoringVital signs, fluid intake/output, baseline electrolytes
Administration SetupCentral venous catheter required.
Pregnancy SafetyCategory C (FDA). Animal reproduction studies have not been conducted. Should be given to a pregnant woman only if clearly needed.
StorageRoom temperature. Protect from freezing.
Prescription Status Rx Only

Clinical Disclaimer: Data compiled from FDA DailyMed, Baxter/Fresenius prescribing information, and USP monographs. Always verify against the physical product label, your institution's IV protocols, and current pharmacist guidance before administration.